regulusrx.comHome - Regulus Therapeutics

regulusrx.com Profile

regulusrx.com

Title:Home - Regulus Therapeutics

Description：TOGETHER WE... believe that microRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease.

Discover regulusrx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

regulusrx.com Information

Website / Domain:	regulusrx.com
HomePage size:	42.502 KB
Page Load Time:	0.876145 Seconds
Website IP Address:	67.222.32.150
Isp Server:	Unified Layer

regulusrx.com Ip Information

Ip Country:	United States
City Name:	Provo
Latitude:	40.21390914917
Longitude:	-111.6340713501

regulusrx.com Keywords accounting

Keyword	Count

regulusrx.com Httpheader

Date: Wed, 25 Nov 2020 16:49:47 GMT
Server: Apache
Link: http://regulusrx.com/wp-json/; rel="https://api.w.org/", http://regulusrx.com/; rel=shortlink
Upgrade: h2,h2c
Connection: Upgrade, Keep-Alive
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 9812
Keep-Alive: timeout=5, max=75
Content-Type: text/html; charset=UTF-8

regulusrx.com Meta Info

content="http://regulusrx.com" property="og:url"/
content="article" property="og:type"/
content="Regulus Therapeutics - Leading the Way in the Discovery and Development of microRNA Therapeutics" property="og:title"/
content="TOGETHER WE... believe that microRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease." property="og:description"/
content="http://regulusrx.com/wp-content/themes/regulus/wp-content/themes/regulus/screenshot.png" property="og:image"/
charset="utf-8"/
content="width=device-width" name="viewport"/
content="en_US" property="og:locale"
content="website" property="og:type"
content="Home - Regulus Therapeutics" property="og:title"/
content="TOGETHER WE… believe that microRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease." property="og:description"/
content="http://regulusrx.com/" property="og:url"/
content="Regulus Therapeutics" property="og:site_name"/
content="summary" name="twitter:card"/
content="TOGETHER WE… believe that microRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease." name="twitter:description"/
content="Home - Regulus Therapeutics" name="twitter:title"/
content="WordPress 5.2.9" name="generator"/

67.222.32.150 Domains

Domain	WebSite Title

regulusrx.com Similar Website

Domain	WebSite Title
regulusrx.com	Home - Regulus Therapeutics
ir.regulusrx.com	INVESTORS \| Regulus Therapeutics Inc.
cempra.com	Home - Melinta Therapeutics
mct.aacrjournals.org	Home \| Molecular Cancer Therapeutics
jpet.aspetjournals.org	Home \| Journal of Pharmacology and Experimental Therapeutics
ir.nektar.com	About Us \| Nektar Therapeutics
sparktx.com	Spark Therapeutics
unither.com	United Therapeutics
ir.flexiontherapeutics.com	Investors \| Flexion Therapeutics, Inc.
jobs.ebbsleep.com	Careers \| Ebb Therapeutics
bioxceltherapeutics.com	BioXcel Therapeutics, Inc. (BTAI)
checkpointtx.com	Overview Checkpoint Therapeutics
login.primetherapeutics.com	Prime Therapeutics Login
ir.checkpointtx.com	Overview \| Checkpoint Therapeutics
ir.tgtherapeutics.com	Investor Relations \| TG Therapeutics, Inc.

regulusrx.com Traffic Sources Chart

regulusrx.com Alexa Rank History Chart

regulusrx.com Html To Plain Text

here1 here2 Search Search for: Primary Menu Skip to content About About Management Directors Advisors Programs Pipeline Alport Syndrome ADPKD Platform About micro RNAs Platform Technology Biology & Pharmacology Intellectual Property News Publications Investors Overview Stock Information Historic Stock Lookup Investment Calculator Analyst Coverage Ownership Profile FORM 8937 Corporate Governance Management Board of Directors Committee Composition Financials & Filings SEC Filings Annual Reports Quarterly Results Press Releases Events & Presentations Investor FAQs Contact Us Careers Current Openings Working at Regulus Internships Benefits Keeping our RGLS Family Healthy Compensation and Financial Rewards Time to Recharge In the Community Contact Together We... TOGETHER WE… believe that microRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease. Believe Achieve Nov 05, 2020 | Regulus Therapeutics Reports Third Quarter 2020 Financial Results and Recent Updates » Nov 02, 2020 | Regulus Therapeutics Announces Achievement of Interim Enrollment Milestone Under Collaboration with Sanofi » Oct 15, 2020 | Regulus Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal... » micro RNA MOA © 2020 Regulus Therapeutics Inc. - All Rights Reserved Home | Site Map |-- Legal | Contact MENU About About Management Directors Advisors Programs Pipeline Alport Syndrome ADPKD Platform About micro RNAs Platform Technology Biology & Pharmacology Intellectual Property News Publications Investors Overview Stock Information Historic Stock Lookup Investment Calculator Analyst Coverage Ownership Profile FORM 8937 Corporate Governance Management Board of Directors Committee Composition Financials & Filings SEC Filings Annual Reports Quarterly Results Press Releases Events & Presentations Investor FAQs Contact Us Careers Current Openings Working at Regulus Internships Benefits Keeping our RGLS Family Healthy Compensation and Financial Rewards Time to Recharge In the Community Contact...

regulusrx.com Whois

"domain_name": "REGULUSRX.COM", "registrar": "GoDaddy.com, LLC", "whois_server": "whois.godaddy.com", "referral_url": null, "updated_date": [ "2018-12-17 21:42:14", "2018-12-17 21:42:13" ], "creation_date": "2007-01-03 21:42:22", "expiration_date": "2024-01-03 21:42:22", "name_servers": [ "NS51.DOMAINCONTROL.COM", "NS52.DOMAINCONTROL.COM" ], "status": [ "clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited", "clientRenewProhibited https://icann.org/epp#clientRenewProhibited", "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited", "clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited", "clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited", "clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited", "clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited" ], "emails": "abuse@godaddy.com", "dnssec": "unsigned", "name": null, "org": "Regulus Therapeutics, LLC.", "address": null, "city": null, "state": "California", "zipcode": null, "country": "US"